Last reviewed · How we verify
OXP001
At a glance
| Generic name | OXP001 |
|---|---|
| Sponsor | Oxford Pharmascience Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pilot Study of OXP001(2) and Brufen in Healthy Subjects (PHASE1)
- Pilot Study of OXP001 and Brufen in Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |